Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables "Electro"
Completed
Phase 2 Results N/AView Trial Locations
Recruitment
- Enrollment: 32
- Gender: Both
- Minimum Age: 50 Years
- Accepts Healthy Volunteers: No
- 7 locations, 4 countries
Principal Investigators
- Irja Korpela
Orion Corporation, Orion Pharma
- Risto O. Roine, M.D., Ph.D.
Turku University Hospital